Sotyktu (Deucravacitinib): A New Hope for Plaque Psoriasis in India

Understanding Sotyktu (Deucravacitinib) for Plaque Psoriasis

Plaque psoriasis is a chronic autoimmune condition that affects millions worldwide, including many in India. It causes red, scaly patches on the skin, leading to discomfort, itching, and sometimes pain. While various treatments exist, the search for more effective and targeted therapies continues. Sotyktu, with its active ingredient deucravacitinib, represents a significant advancement in managing moderate to severe plaque psoriasis in adults.

What is Sotyktu and How Does it Work?

Sotyktu is a prescription oral tablet that belongs to a class of drugs known as tyrosine kinase 2 (TK2) blockers. Unlike biologic drugs, which are derived from living cells, Sotyktu is a small molecule drug synthesized through chemical processes. Its mechanism of action involves targeting and blocking the TK2 enzyme in the body. This enzyme is believed to play a crucial role in the inflammatory pathways that contribute to plaque psoriasis. By inhibiting TK2, Sotyktu effectively reduces inflammation, thereby alleviating the symptoms associated with the condition.

It is important to understand that Sotyktu is an immunosuppressant. This means it works by reducing the activity of your immune system. While this is essential for controlling the overactive immune response in psoriasis, it also means an increased risk of infections. Therefore, it is generally not recommended for use with other strong immunosuppressants, as this could excessively lower immune system activity and heighten the risk of serious infections like COVID-19 or tuberculosis.

Who Can Benefit from Sotyktu?

Sotyktu is prescribed for adults who have moderate to severe plaque psoriasis. It is an option for individuals who may benefit from phototherapy or other systemic treatments. The decision to use Sotyktu should be made in consultation with a healthcare professional who can assess the severity of the condition and the patient's overall health status.

Dosage and Administration

Sotyktu is available as an oral tablet in a single strength of 6 milligrams (mg). The recommended dosage for treating plaque psoriasis is 6 mg, taken once daily. It is crucial to follow the dosage instructions provided by your doctor and to take the medication as prescribed. Do not alter the dosage or stop taking the medication without consulting your doctor.

Potential Side Effects of Sotyktu

Like all medications, Sotyktu can cause side effects, ranging from mild to serious. It is essential to be aware of these potential effects and to discuss them thoroughly with your doctor before starting treatment.

Common Mild Side Effects:

• Mild upper respiratory infections (e.g., sinus infections)
• Mouth sores (stomatitis)
• Acne
• Reactivation of herpes infections (if you have a history of contracting the virus)
• Folliculitis (inflammation of hair follicles)
• Elevated levels of triglycerides (a type of fat in the blood)

Your doctor or pharmacist can provide more detailed information on managing these mild side effects and suggest ways to minimize discomfort.

Serious Side Effects:

While not common, Sotyktu can lead to serious side effects. It is imperative to seek immediate medical attention if you experience any of the following:

• Increased risk of serious infections: This includes infections like pneumonia and COVID-19. Symptoms may include fever, cough, shortness of breath, fatigue, or chills.
• Severe allergic reactions: Symptoms can include swelling of the face, lips, tongue, or throat, and difficulty breathing. If you experience these, call emergency services (like 108 or 112 in India) immediately.
• Potential increased risk of certain cancers: Discuss your personal health history and any risk factors with your doctor.

Important Note: Sotyktu is an immunosuppressant. If you have any signs of infection, such as fever, persistent cough, or feeling unwell, contact your doctor immediately. Do not take Sotyktu if you have an active serious infection.

Drug Interactions

It is vital to inform your doctor about all medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. As mentioned earlier, Sotyktu should not be used with other strong immunosuppressants due to the increased risk of infection. Your doctor will review your medication list to ensure Sotyktu is safe for you.

Cost and Availability in India

Sotyktu is currently available only as a brand-name drug in India, and a generic version is not yet available. The cost can be a significant factor for patients. Healthline mentions a savings program called Sotyktu 360 Support, which may offer resources to help manage prescription costs. Patients in India should discuss payment options and potential assistance programs with their doctor or pharmacist. You can also inquire about the drug's website for more information on support programs.

When to Consult a Doctor

It is essential to consult a doctor under the following circumstances:

• If you are considering Sotyktu for plaque psoriasis.
• If you experience any new or worsening symptoms of psoriasis.
• If you develop any signs of infection while taking Sotyktu.
• If you experience any severe side effects, such as difficulty breathing or swelling.
• If you have concerns about the cost or availability of the medication.
• If you have pre-existing health conditions, especially those affecting your immune system or liver.

The Road to Relief: Patience and Monitoring

It's important to note that it may take time to see the full effects of Sotyktu. Reaching the drug’s maximum benefit and significant symptom relief can take approximately 4 to 6 months of consistent use. Therefore, patience and adherence to the treatment plan are key. Regular follow-up appointments with your doctor are crucial for monitoring your progress, managing potential side effects, and ensuring the continued effectiveness of the treatment.

Conclusion

Sotyktu (deucravacitinib) offers a promising new avenue for adults in India struggling with moderate to severe plaque psoriasis. As a targeted small molecule drug, it works by reducing inflammation associated with the condition. However, like all potent medications, it comes with potential risks, particularly concerning infections. A thorough discussion with your healthcare provider is paramount to determine if Sotyktu is the right choice for your individual needs, considering its benefits, potential side effects, and interactions. With proper medical guidance and monitoring, Sotyktu can be a valuable tool in achieving clearer, healthier skin and improving the quality of life for those affected by plaque psoriasis.